SCHEMBL902225

SCHEMBL902225

COc1ccc(C(CC2(O)CCCCC2)N(C)C)cc1

nearest known ligand 0.56

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 11/20 0.56
SLC6A4 P31645 10/20 0.56
SLC6A3 Q01959 9/20 0.56
LMNA P02545 1/20 0.56
CNR1 P21554 1/20 0.56
HTR2A P28223 1/20 0.56
HRH1 P35367 1/20 0.56
HRH3 Q9Y5N1 1/20 0.56
KMT2A Q03164 1/20 0.46
ALDH1A1 P00352 1/20 0.44
CACNA1F O60840 1/20 0.43
CACNA1D Q01668 1/20 0.43
CACNA1S Q13698 1/20 0.43
CACNA1C Q13936 1/20 0.43
OPRM1 P35372 1/20 0.42
OPRD1 P41143 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4967524 1.00 SLC6A2 (0.56) SLC6A2SLC6A4SLC6A3LMNACNR1
SCHEMBL2761798 1.00 SLC6A2 (0.56) SLC6A2SLC6A4SLC6A3LMNACNR1
Hydrochloric Acid SCHEMBL3349919 0.99 SLC6A2 (0.56) SLC6A2SLC6A4SLC6A3LMNACNR1
Hydrochloric Acid SCHEMBL4739317 0.99 SLC6A2 (0.56) SLC6A2SLC6A4SLC6A3LMNACNR1
SCHEMBL8028845 0.84 SLC6A2 (0.52) SLC6A2SLC6A4SLC6A3LMNACNR1
SCHEMBL902452 0.84 SLC6A2 (0.52) SLC6A2SLC6A4SLC6A3LMNACNR1
SCHEMBL8028820 0.84 SLC6A2 (0.52) SLC6A2SLC6A4SLC6A3LMNACNR1
SCHEMBL4111320 0.82 SLC6A2 (0.39) SLC6A2SLC6A4SLC6A3LMNACNR1
SCHEMBL4627006 0.82 OPRM1 (0.39) SLC6A2SLC6A4SLC6A3LMNACNR1
SCHEMBL4632472 0.82 CHRNB2 (0.43) SLC6A2SLC6A4SLC6A3LMNAHRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 91 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0700289-A1 ANTIDEPRESSANT DOSAGE FORM ALZA CORPORATION (US) 1996-03-13 EP claimed
WO-1994027589-A2 ANTIDEPRESSANT DOSAGE FORM ALZA CORPORATION (US) 1994-12-08 WO claimed
EP-2950799-A2 TREATMENTS FOR DEPRESSION AND OTHER DISEASES WITH A LOW DOSE AGENT Pharmorx Therapeutics, Inc. (US) 2015-12-09 EP disclosed
EP-2934487-A1 FILM COATED PELLETS ratiopharm GmbH (DE) 2015-10-28 EP disclosed
WO-2014120936-A2 TREATMENTS FOR DEPRESSION AND OTHER DISEASES WITH A LOW DOSE AGENT PHARMORX THERAPEUTICS, INC. (US) 2014-08-07 WO disclosed
WO-2014096124-A1 FILM COATED PELLETS RATIOPHARM GMBH (DE) 2014-06-26 WO disclosed
EP-2621891-A1 POLYMORPHS OF 4-[2-DIMETHYLAMINO-1-(1-HYDROXYCYCLOHEXYL)ETHYL]PHENYL 4-METHYLBENZOATE HYDROCHLORIDE, METHODS FOR PREPARING THE SAME AND USE OF THE SAME Shan Dong Luye Pharmaceutical Co., Ltd. (CN) 2013-08-07 EP disclosed
WO-2012041013-A1 POLYMORPHS OF 4-[2-DIMETHYLAMINO-1-(1-HYDROXYCYCLOHEXYL)ETHYL]PHENYL 4-METHYLBENZOATE HYDROCHLORIDE, METHODS FOR PREPARING THE SAME AND USE OF THE SAME SHAN DONG LUYE PHARMACEUTICAL CO., LTD. (CN) 2012-04-05 WO disclosed
EP-2252574-A1 PROCESSES FOR THE PREPARATION OF O-DESMETHYLVENLAFAXINE, FREE FROM ITS DIMER IMPURITIES Teva Pharmaceutical Industries Ltd. (IL) 2010-11-24 EP disclosed
WO-2010028130-A2 ANTIDEPRESSANT COMPOUNDS CONCERT PHARMACEUTICALS, INC. (US) 2010-03-11 WO disclosed
WO-2009151494-A1 PROCESSES FOR THE PREPARATION OF O-DESMETHYLVENLAFAXINE, FREE FROM ITS DIMER IMPURITIES TEVA PHARMACEUTICAL INDUSTRIES LTD. (IL) 2009-12-17 WO disclosed
EP-1135359-A1 DERIVATIVES OF (-)-VENLAFAXINE AND METHODS OF PREPARING AND USING THE SAME Sepracor Inc. (US) 2001-09-26 EP disclosed
EP-1135358-A1 DERIVATIVES OF (+)-VENLAFAXINE AND METHODS OF PREPARING AND USING THE SAME Sepracor Inc. (US) 2001-09-26 EP disclosed
WO-2000076956-A2 ENANTIOMERS OF N-DESMETHYL VENLAFAXINE AMERICAN HOME PRODUCTS CORPORATION (US) 2000-12-21 WO disclosed
WO-2000076955-A1 ENANTIOMERS OF O-DESMETHYL VENLAFAXINE AMERICAN HOME PRODUCTS CORPORATION (US) 2000-12-21 WO disclosed
WO-2000059851-A1 DERIVATIVES OF VENLAFAXINE AND METHODS OF PREPARING AND USING THE SAME SEPRACOR INC. (US) 2000-10-12 WO disclosed
EP-1028718-A2 EXTENDED RELEASE FORMULATION CONTAINING VENLAFAXIN AMERICAN HOME FOOD PRODUCTS, INC. (US) 2000-08-23 EP disclosed
WO-2000032556-A1 DERIVATIVES OF (-)-VENLAFAXINE AND METHODS OF PREPARING AND USING THE SAME SEPRACOR INC. (US) 2000-06-08 WO disclosed
WO-2000032555-A1 DERIVATIVES OF (+)-VENLAFAXINE AND METHODS OF PREPARING AND USING THE SAME SEPRACOR INC. (US) 2000-06-08 WO disclosed
WO-1999022724-A2 EXTENDED RELEASE FORMULATION CONTAINING VENLAFAXIN AMERICAN HOME PRODUCTS CORPORATION (US) 1999-05-14 WO disclosed